$PACB Cashflow Statement | Understand Stock

$PACB

$2.83 +$0.38 (15.51%) Close

$PACB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Loss (gain) from Continuation Advances
Depreciation
Amortization of debt discount and financing costs
Amortization of intangible assets
Amortization of right-of-use assets
Share-based compensation expense
Impairment charges
Merger-related compensation expense
Loss on extinguishment of debt
Gain on debt restructuring
Accretion of discount and amortization of premium on marketable securities, net
Change in fair value of contingent consideration
Inventory provision
Loss on disposition of equipment
Deferred income taxes
Other
Changes in assets and liabilities
Accounts receivable, net
Inventory, net
Prepaid expenses and other assets
Accounts payable
Accrued expenses
Deferred revenue
Operating lease liabilities
Contingent consideration liability
Other liabilities

Net cash used in operating activities
Cash flows from investing activities
Purchase of property and equipment
Purchase of intangible assets
Cash paid for purchases of acquired entities, net of cash acquired
Circulomics, Inc
Omniome, Inc
Total cash paid for purchases of acquired entities, net of cash acquired

Purchase of investments
Sales of investments
Maturities of investments
Net cash provided by investing activities
Cash flows from financing activities
Continuation Advances
Proceeds from issuance of Convertible Senior Notes, net of issuance costs
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs
Proceeds from issuance of common stock under equity offerings, net of issuance costs
Proceeds from issuance of common stock from equity plans
Payment of debt issuance costs
Payment of contingent consideration
Payments made in conjunction with convertible notes exchange
Notes payable principal payoff
Other
Net cash provided by (used in) financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental disclosure of cash flow information
Interest paid
Supplemental disclosure of non-cash investing and financing activities
Inventory transferred to property and equipment
Apton And Omniome
Total inventory transferred to property and equipment

Property and equipment transferred to inventory
Right-of-use asset and liability additions and modifications
Apton And Omniome
Total right-of-use asset and liability additions and modifications
Issuance of common stock
Note Exchange
Liquidity Bonus Event
Milestone Achievement
Convertible notes exchange
Cash and cash equivalents at end of period
Restricted cash at end of period

Comments